INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)
$10.736 -1.408 (-11.5942%)
Analysed INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) News Sources
Eli Lilly transfers China rights for Verzenios to Innovent Biologics
30-06-2026
qz.com
Eli Lilly Hands China Sales Rights for Verzenio to Innovent
30-06-2026
yahoo.com
Eli Lilly and Innovent agree Verzenios commercialisation deal in China
01-07-2026
pharmaceutical-technology.com
Lilly quietly hands Chinese partner its cancer drug
06-07-2026
thestreet.com
Eli Lilly (LLY) Expands R And D Reach With Abbisko And China Drug Handover
07-07-2026
yahoo.com
Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
07-07-2026
yahoo.com
Innovent’s China Verzenios Deal and New Jaypirca Nod Might Change The Case For Investing In Eli Lilly (LLY)
09-07-2026
yahoo.com
Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
14-07-2026
yahoo.com
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
14-07-2026
yahoo.com
Innovent licenses IBI355 rights to Spero for up to $1.1bn
15-07-2026
hospitalmanagement.net
What is the current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is $10.736.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is $-1.408.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is -11.5942%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.